BioSpace News Archive

Manhattan Scientifics Inc., initially funded and is the current owner of more that 50 million shares of Imagion Biosystems Ltd..

Incyte announced that multiple abstracts highlighting data from its oncology portfolio will be presented at the Society for Immunotherapy of Cancer’s 36th Annual Meeting, held from November 10-14, 2021 in Washington, D.C and virtually.

Apollo Endosurgery, Inc. announced the publication of a multi-center study of the X-Tack System in closing challenging gastrointestinal defects.

Galmed Pharmaceuticals Ltd. announced today results from the first 16 patients in the Open-Label Part of the ARMOR Phase 3 study who underwent a scheduled post-baseline biopsy.

Aurinia Pharmaceuticals Inc. today announced updated interim results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of LUPKYNIS™ (voclosporin) for the treatment of lupus nephritis (LN) in patients with systemic lupus erythematosus (SLE), a chronic and complex autoimmune disease.

Developed in collaboration with Teva Pharmaceuticals, mdc-IRM, a risperidone extended-release injectable suspension for the treatment of patients with schizophrenia

Koning begins an FDA screening trial this month for their no-compression, Isotropic, 3-dimensional breast imaging device.

Oncopeptides AB today announces that the company has appointed Annika Muskantor as interim Chief Financial Officer, CFO.

BioSig Technologies, Inc., a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, announced that it exceeded its procedural target of 1500 patient cases in 2021.

ANI Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved the Company’s supplemental New Drug Application for Purified Cortrophin™ Gel for the treatment of certain chronic autoimmune disorders, including acute exacerbations of multiple sclerosis and rheumatoid arthritis, in addition to excess urinary protein due to nephrotic syndrome.